Ko J M, Cheung M H, Kwan M W, Wong C M, Lau K W, Tang C M, Lung M L
Department of Biology, Hong Kong University of Science and Technology, Clear Water Bay, Kowloon, Hong Kong, People's Republic of China.
Int J Cancer. 1999 Aug 20;84(4):404-9. doi: 10.1002/(sici)1097-0215(19990820)84:4<404::aid-ijc13>3.0.co;2-l.
Our aim was to reveal the significance of tumor-suppressor genes and genomic instability in 99 Hong Kong Chinese colorectal carcinoma (CRC) patients by PCR-LOH analysis and PCR-PTT assay. The frequencies of allelic loss of Apc, Mcc and Dcc and of APC truncation were 31.3% (15/48), 11.6% (5/43), 44.4% (20/45) and 46/93 (49.5%), respectively. The frequency of Apc LOH was similar to, the Mcc LOH was lower than, and the Dcc LOH was higher than that reported for Caucasians and Japanese. In Hong Kong CRC patients, the replication error-positive (RER(+)) phenotype occurred with a frequency of 10% (10/99), which was similar to other results using microsatellite markers where RER(+) frequencies ranged from 11% to 28%. The rates of genetic alteration in RER(+) tumors were lower in tumors harboring p53, Mcc and Dcc alterations; similar in Apc; and higher in Ki-ras tumors compared with RER(-) tumors, though these differences did not achieve statistical significance. None of the biomarkers examined were predictive of survival independently, but strong trends confirming earlier observations of associations between RER(+) phenotypes with proximal tumor location and poorly differentiated tumor status were noted. The RER(+) phenotype was correlated significantly to the less aggressive Duke's stage B and improved prognosis. Additionally, tumors with RER(+) phenotypes were positively correlated with young age and sex. Our results support the observation that a subset of younger male CRC patients in Hong Kong may develop CRC via the RER pathway and show differences in RER status and sex. A significantly higher percentage of older Hong Kong Chinese CRC patients had APC truncations. Int. J. Cancer (Pred. Oncol.) 84:404-409, 1999.
我们的目的是通过聚合酶链反应-杂合性缺失分析(PCR-LOH)和聚合酶链反应-蛋白质截短检测(PCR-PTT),揭示99例香港中国结直肠癌(CRC)患者中肿瘤抑制基因和基因组不稳定性的意义。Apc、Mcc和Dcc等位基因缺失频率以及APC截短频率分别为31.3%(15/48)、11.6%(5/43)、44.4%(20/45)和46/93(49.5%)。Apc杂合性缺失频率与白种人和日本人报道的相似,Mcc杂合性缺失频率低于白种人和日本人,而Dcc杂合性缺失频率高于白种人和日本人。在香港结直肠癌患者中,复制错误阳性(RER(+))表型出现频率为10%(10/99),这与使用微卫星标记的其他结果相似,其中RER(+)频率范围为11%至28%。与RER(-)肿瘤相比,RER(+)肿瘤中携带p53、Mcc和Dcc改变的肿瘤遗传改变率较低;Apc改变的肿瘤相似;Ki-ras肿瘤中较高,尽管这些差异未达到统计学意义。所检测的生物标志物均不能独立预测生存,但注意到有强烈趋势证实了早期关于RER(+)表型与近端肿瘤位置和低分化肿瘤状态之间关联的观察结果。RER(+)表型与侵袭性较小的杜克B期显著相关且预后改善。此外,具有RER(+)表型的肿瘤与年轻年龄和性别呈正相关。我们的结果支持这样的观察结果,即香港一部分年轻男性结直肠癌患者可能通过RER途径发生结直肠癌,并且在RER状态和性别上存在差异。年龄较大的香港中国结直肠癌患者中APC截短的比例显著更高。《国际癌症杂志(预测肿瘤学)》84:404 - 409,1999年。